DrugPatentWatch Database Preview
Ammonium chloride - Generic Drug Details
What are the generic drug sources for ammonium chloride and what is the scope of patent protection?
Ammonium chloride
is the generic ingredient in four branded drugs marketed by Abbott, Gd Searle Llc, Mcgaw, B Braun, and Hospira, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.There are forty drug master file entries for ammonium chloride.
Summary for ammonium chloride
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 5 |
| NDAs: | 5 |
| Drug Master File Entries: | 40 |
| Bulk Api Vendors: | 53 |
| Clinical Trials: | 3 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ammonium chloride at DailyMed |
Recent Clinical Trials for ammonium chloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Mercy Hospital Kansas City | Phase 1 |
| American Heart Association | Phase 1 |
| University Hospitals Cleveland Medical Center | N/A |
US Patents and Regulatory Information for ammonium chloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | AMMONIUM CHLORIDE 2.14% | ammonium chloride | INJECTABLE;INJECTION | 085734-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Gd Searle Llc | AMMONIUM CHLORIDE | ammonium chloride | INJECTABLE;INJECTION | 086205-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Hospira | AMMONIUM CHLORIDE IN PLASTIC CONTAINER | ammonium chloride | INJECTABLE;INJECTION | 088366-001 | Jun 13, 1984 | RX | No | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
